Goldman Sachs
DTIL icon

Goldman Sachs’s Precision BioSciences DTIL Stock Holding History

Goldman Sachs’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-387
Closed -$97K – 6122
2020
Q4 		$97K Buy
+387
New +$94.8K ﹤0.01% 5297

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Goldman Sachs's DTIL Position: Q2 2026 in Review

Goldman Sachs increased its Precision BioSciences (DTIL) stake by 252% in Q2 2026, buying an estimated $704K and bringing the position to 139,828 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #5141.

Goldman Sachs first reported a position in DTIL in Q1 2019 and has held it in 25 quarters since. The position peaked at $7.61M in Q3 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Goldman Sachs held 139,828 shares of Precision BioSciences worth $1.1M as of Q2 2026.
  • Goldman Sachs bought 100,076 Precision BioSciences shares in Q2 2026, an estimated $704K.
  • Precision BioSciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5141 holding.
  • Goldman Sachs first reported a position in Precision BioSciences in Q1 2019 and has held it in 25 quarters since.
  • Goldman Sachs's Precision BioSciences position peaked at $7.61M in Q3 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.